Chloe Thio

Medicine & Life Sciences

1. Acquired Immunodeficiency Syndrome 12%
2. African Americans 10%
3. Alleles 10%
4. Antiviral Agents 13%
5. CD4 Lymphocyte Count 10%
6. Chronic Hepatitis B 28%
7. Cohort Studies 14%
8. Coinfection 32%
9. Communicable Diseases 7%
10. Confidence Intervals 14%
11. DNA 11%
12. entecavir 8%
13. Fibrosis 6%
14. Genes 11%
15. Genome-Wide Association Study 10%
16. Genomics 7%
17. Genotype 12%
18. Haplotypes 13%
19. Hepacivirus 77%
20. Hepatitis 9%
21. Hepatitis B 55%
22. Hepatitis B e Antigens 8%
23. Hepatitis B Surface Antigens 10%
24. Hepatitis B virus 100%
25. Hepatitis C 21%
26. Hepatitis C Antibodies 8%
27. Hepatitis Viruses 9%
28. Highly Active Antiretroviral Therapy 22%
29. HIV 98%
30. HIV Infections 14%
31. HIV-1 20%
32. HLA Antigens 13%
33. Infections 10%
34. Interferons 11%
35. KIR Receptors 7%
36. Lamivudine 22%
37. Liver 9%
38. Liver Cirrhosis 9%
39. Liver Diseases 14%
40. Mortality 7%
41. Nigeria 8%
42. Odds Ratio 15%
43. RNA 9%
44. Sexual and Gender Minorities 12%
45. Single Nucleotide Polymorphism 18%
46. Tenofovir 19%
47. Therapeutics 13%
48. Vertical Infectious Disease Transmission 15%
49. Virus Diseases 41%
50. Viruses 7%